Zalm Therapeutics Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

Zalm Therapeutics General Information

Description

Manufacturer of GMP-grade medicinal cannabis products for New Zealand and global markets. The company offers oils, dried flowers and wellness products designed to be taken orally as well as a comprehensive digital platform to provide upfront and ongoing support for the use of products.

Contact Information

Website
www.zalm.com
Formerly Known As
Pure Cann NZ, Pure Cann
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Forsyth Barr, Level 23
  • The Lumley Centre, 88 Shortland Street
  • Auckland, 1140
  • New Zealand
Primary Industry
Personal Products
Acquirer
Corporate Office
  • Forsyth Barr, Level 23
  • The Lumley Centre, 88 Shortland Street
  • Auckland, 1140
  • New Zealand

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Zalm Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Zalm Therapeutics‘s full profile, request access.

Request a free trial

Zalm Therapeutics Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Zalm Therapeutics‘s full profile, request access.

Request a free trial

Zalm Therapeutics FAQs

  • When was Zalm Therapeutics founded?

    Zalm Therapeutics was founded in 2018.

  • Where is Zalm Therapeutics headquartered?

    Zalm Therapeutics is headquartered in Auckland, New Zealand.

  • What industry is Zalm Therapeutics in?

    Zalm Therapeutics’s primary industry is Personal Products.

  • Is Zalm Therapeutics a private or public company?

    Zalm Therapeutics is a Private company.

  • What is the current valuation of Zalm Therapeutics?

    The current valuation of Zalm Therapeutics is .

  • What is Zalm Therapeutics’s current revenue?

    The current revenue for Zalm Therapeutics is .

  • How much funding has Zalm Therapeutics raised over time?

    Zalm Therapeutics has raised $1.33M.

  • Who are Zalm Therapeutics’s investors?

    Cann Group has invested in Zalm Therapeutics.

  • When was Zalm Therapeutics acquired?

    Zalm Therapeutics was acquired on 19-Jan-2022.

  • Who acquired Zalm Therapeutics?

    Zalm Therapeutics was acquired by Rua Bioscience.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process